Clinical Trials Browser

INDUSTRY × Lymphoma, Non-Hodgkin × TAK-981 × Clear all

NCT04074330 2024-06-14

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Phase 1/2 Terminated

38 enrolled 44 charts

Lymphoma, Non-Hodgkin